Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:


Articles on the impact, diagnosis and treatment of the novel coronavirus and COVID-19

Everest in $500 Million Deal for mRNA Products, including COVID-19 Vaccine

Sinovac Says Third Dose of COVID-19 Vaccine Protects Against Delta Variant

Clover Bio Awarded Manufacturing Permit for S-Trimer COVID-19 Vaccine

Brii Bio Allocates $100 Million to Bring Dual SARS-CoV-2 mAb Therapy to Market

Brii Bio Says Dual mAb Therapy Effective in Early Stage COVID-19 Patients

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021